Research & Development



  雲瑯笑道︰“既然你的軍隊全是騎兵,別的忙我幫不上你,改造一下你的騎兵我還是能做到的。”   很不幸,曹襄因為有一個長公主母親,所以他接受的就是大漢國最高級的皇家教育。3.6亿中奖彩票 第一五三章 不畏人言東方朔24日福利彩票出奖号码   李敢笑道,“你家的水車就是一圈大勺子在舀水,這里的水車可是真正的水車,你看看,水流沖下來的時候幾乎半點不灑的流進了水槽里。”   曹襄怒罵道︰“我知道你看上我的那套掐絲金棋盤了,要是能成,他就是你的。”2014河北竞彩彩票站   不由得嘆息一聲道︰“看來我吃錯了?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo